title: Langerhans cell histiocytosis in a child with non-Hodgkin lymphoma.
authors.forename: Bibi Shahin
authors.initials: BS
authors.lastname: Shamsian
authors.forename: Kourosh
authors.initials: K
authors.lastname: Goudarzipour
authors.forename: Samin
authors.initials: S
authors.lastname: Alavi
authors.forename: Farzaneh
authors.initials: F
authors.lastname: Jadali
authors.forename: Atoosa
authors.initials: A
authors.lastname: Gharib
authors.forename: Roxana
authors.initials: R
authors.lastname: Aghakhani
authors.forename: Mohammad Taghi
authors.initials: MT
authors.lastname: Arzanian
authors.forename: Nima
authors.initials: N
authors.lastname: Rezaei
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000627:therapeutic use; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D003561:Cytarabine; D014750:Vincristine; D014747:Vinblastine; D016572:Cyclosporine; D003520:Cyclophosphamide; D011239:Prednisolone; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate